We are proud to announce the incorporation of Nioside® Launch into our Pulmonology Division. This treatment is indicated for...
14
Aug
At Aspen Laboratorios, we are pleased to introduce Vaxtor® (Ivacaftor), now part of our Oncology Division. Indicated for the...
We are proud to announce the incorporation of Uveren® (Macitentan) into our Pulmonology Division. This treatment is indicate...